MFAP2 expression was also correlated with chemokine receptors in gliomas, such as CCR3, CCR7, CXCR4, and CXCR6, which were significantly associated with MFAP2 expression in both LGG and GBM (Figure 5). The gene discussed is CXCR6; the disease is central nervous system cancer.